Effect of platelet reactivity, endothelial function, and inflammatory status on outcomes in patients with stable angina pectoris on clopidogrel therapy

American Journal of Cardiology

Volumn 113, Issue 5, 2014, Pages 786-792

  Woo, Jong Shin ^a   Kim, Weon ^a   Jang, Hyun Hee ^a   Kim, Jin Bae ^a   Kim, Woo Shik ^a   Kim, Kwon Sam ^a  

^a Kyung Hee University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANGINA, STABLE; BLOOD PLATELETS; BRACHIAL ARTERY; CELL COUNT; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; STEM CELLS; TICLOPIDINE;

EID: 84893915758     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2013.11.025     Document Type: Article

References (29)

1. D.J. Angiolillo, A. Fernandez-Ortiz, E. Bernardo, C. Ramirez, M. Sabate, P. Jimenez-Quevedo, R. Hernandez, R. Moreno, J. Escaned, F. Alfonso, C. Banuelos, M.A. Costa, T.A. Bass, and C. Macaya Clopidogrel withdrawal is associated with proinflammatory and prothrombotic effects in patients with diabetes and coronary artery disease Diabetes 55 2006 780 784
2. L.A. Malek, M. Grabowski, M. Spiewak, K.J. Filipiak, M. Szpotanska, T. Imiela, Z. Huczek, D. Bobilewicz, and G. Opolski Relation between impaired antiplatelet response to clopidogrel and possible pleiotropic effects J Thromb Thrombolysis 24 2007 301 305
3. O. Muller, M. Hamilos, J. Bartunek, H. Ulrichts, F. Mangiacapra, J.B. Holz, A. Ntalianis, C. Trana, K. Dierickx, K. Vercruysse, B. De Bruyne, W. Wijns, and E. Barbato Relation of endothelial function to residual platelet reactivity after clopidogrel in patients with stable angina pectoris undergoing percutaneous coronary intervention Am J Cardiol 105 2010 333 338
4. D.J. Angiolillo, A. Fernandez-Ortiz, E. Bernardo, C. Ramirez, C. Barrera-Ramirez, M. Sabate, R. Hernandez, R. Moreno, J. Escaned, F. Alfonso, C. Banuelos, M.A. Costa, T.A. Bass, and C. Macaya Identification of low responders to a 300-mg clopidogrel loading dose in patients undergoing coronary stenting Thromb Res 115 2005 101 108
5. J.S. Woo, W. Kim, S.R. Lee, K.H. Jung, W.S. Kim, J.H. Lew, T.W. Lee, and C.K. Lim Platelet reactivity in patients with chronic kidney disease receiving adjunctive cilostazol compared with a high-maintenance dose of clopidogrel: results of the effect of platelet inhibition according to clopidogrel dose in patients with chronic kidney disease (PIANO-2 CKD) randomized study Am Heart J 162 2011 1018 1025
6. D.J. Angiolillo, A. Fernandez-Ortiz, E. Bernardo, F. Alfonso, C. Macaya, T.A. Bass, and M.A. Costa Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives J Am Coll Cardiol 49 2007 1505 1516
7. M. Reyes, A. Dudek, B. Jahagirdar, L. Koodie, P.H. Marker, and C.M. Verfaillie Origin of endothelial progenitors in human postnatal bone marrow J Clin Invest 109 2002 337 346
8. W. Kim, M.H. Jeong, S.H. Cho, J.H. Yun, H.J. Chae, Y.K. Ahn, M.C. Lee, X. Cheng, T. Kondo, T. Murohara, and J.C. Kang Effect of green tea consumption on endothelial function and circulating endothelial progenitor cells in chronic smokers Circ J 70 2006 1052 1057
9. S.J. Ha, W. Kim, J.S. Woo, J.B. Kim, S.J. Kim, W.S. Kim, M.K. Kim, X.W. Cheng, and K.S. Kim Preventive effects of exenatide on endothelial dysfunction induced by ischemia-reperfusion injury via KATP channels Arterioscler Thromb Vasc Biol 32 2012 474 480
10. G. Campo, L. Fileti, N. de Cesare, E. Meliga, A. Furgieri, F. Russo, S. Colangelo, S. Brugaletta, R. Ferrari, and M. Valgimigli Long-term clinical outcome based on aspirin and clopidogrel responsiveness status after elective percutaneous coronary intervention: a 3T/2R (Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel) trial substudy J Am Coll Cardiol 56 2010 1447 1455
11. S.S. Brar, J. ten Berg, R. Marcucci, M.J. Price, M. Valgimigli, H.S. Kim, G. Patti, N.J. Breet, G. DiSciascio, T. Cuisset, and G. Dangas Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention. A collaborative meta-analysis of individual participant data J Am Coll Cardiol 58 2011 1945 1954
12. O. Yousuf, B.D. Mohanty, S.S. Martin, P.H. Joshi, M.J. Blaha, K. Nasir, R.S. Blumenthal, and M.J. Budoff High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link? J Am Coll Cardiol 62 2013 397 408
13. G. Patti, F. Mangiacapra, E. Ricottini, A. Cannata, I. Cavallari, V. Vizzi, A. D'Ambrosio, G. Dicuonzo, and G. Di Sciascio Correlation of platelet reactivity and C-reactive protein levels to occurrence of peri-procedural myocardial infarction in patients undergoing percutaneous coronary intervention (from the ARMYDA-CRP study) Am J Cardiol 111 2013 1739 1744
14. H. Hemingway, P. Philipson, R. Chen, N.K. Fitzpatrick, J. Damant, M. Shipley, K.R. Abrams, S. Moreno, K.S. McAllister, S. Palmer, J.C. Kaski, A.D. Timmis, and A.D. Hingorani Evaluating the quality of research into a single prognostic biomarker: a systematic review and meta-analysis of 83 studies of C-reactive protein in stable coronary artery disease PLoS Med 7 2010 e1000286
15. F. Saia, M. Marino, G. Campo, M. Valgimigli, P. Guastaroba, N. Taglieri, S. Tondi, A. Manari, V. Guiducci, P. Sangiorgio, E. Varani, P. Magnavacchi, R. De Palma, and A. Marzocchi Incidence and outcome of high on-treatment platelet reactivity in patients with non-ST elevation acute coronary syndromes undergoing percutaneous coronary intervention (from the VIP [VerifyNow and Inhibition of Platelet Reactivity] study) Am J Cardiol 112 2013 792 798
16. T. Cuisset, C. Frere, J. Quilici, P.E. Morange, J.P. Mouret, L. Bali, P.J. Moro, M. Lambert, M.C. Alessi, and J.L. Bonnet Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study JACC Cardiovasc Interv 1 2008 649 653
17. M. Valgimigli, G. Campo, N. de Cesare, E. Meliga, P. Vranckx, A. Furgieri, D.J. Angiolillo, M. Sabate, M. Hamon, A. Repetto, S. Colangelo, S. Brugaletta, G. Parrinello, G. Percoco, and R. Ferrari Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel study Circulation 119 2009 3215 3222
18. M.J. Price, D.J. Angiolillo, P.S. Teirstein, E. Lillie, S.V. Manoukian, P.B. Berger, J.F. Tanguay, C.P. Cannon, and E.J. Topol Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trial Circulation 124 2011 1132 1137
19. J.W. Suh, S.P. Lee, K.W. Park, H.Y. Lee, H.J. Kang, B.K. Koo, Y.S. Cho, T.J. Youn, I.H. Chae, D.J. Choi, S.W. Rha, J.H. Bae, T.G. Kwon, J.W. Bae, M.C. Cho, and H.S. Kim Multicenter randomized trial evaluating the efficacy of cilostazol on ischemic vascular complications after drug-eluting stent implantation for coronary heart disease: results of the CILON-T (influence of CILostazol-based triple antiplatelet therapy ON ischemic complication after drug-eluting stenT implantation) trial J Am Coll Cardiol 57 2011 280 289
20. D. Trenk, G.W. Stone, M. Gawaz, A. Kastrati, D.J. Angiolillo, U. Muller, G. Richardt, J.A. Jakubowski, and F.J. Neumann A randomized trial of prasugrel versus clopidogrel in patients with high platelet reactivity on clopidogrel after elective percutaneous coronary intervention with implantation of drug-eluting stents: results of the TRIGGER-PCI (Testing Platelet Reactivity In Patients Undergoing Elective Stent Placement on Clopidogrel to Guide Alternative Therapy With Prasugrel) study J Am Coll Cardiol 59 2012 2159 2164
21. J.P. Collet, T. Cuisset, G. Range, G. Cayla, S. Elhadad, C. Pouillot, P. Henry, P. Motreff, D. Carrie, Z. Boueri, L. Belle, E. Van Belle, H. Rousseau, P. Aubry, J. Monsegu, P. Sabouret, S.A. O'Connor, J. Abtan, M. Kerneis, C. Saint-Etienne, O. Barthelemy, F. Beygui, J. Silvain, E. Vicaut, and G. Montalescot Bedside monitoring to adjust antiplatelet therapy for coronary stenting N Engl J Med 367 2012 2100 2109
22. V. Pasceri, J.T. Willerson, and E.T. Yeh Direct proinflammatory effect of C-reactive protein on human endothelial cells Circulation 102 2000 2165 2168
23. F. Krotz, H.Y. Sohn, and U. Pohl Reactive oxygen species: players in the platelet game Arterioscler Thromb Vasc Biol 24 2004 1988 1996
24. D.I. Siegel-Axel, and M. Gawaz Platelets and endothelial cells Semin Thromb Hemost 33 2007 128 135
25. G. Davi, and C. Patrono Platelet activation and atherothrombosis N Engl J Med 357 2007 2482 2494
26. L.K. Jennings Role of platelets in atherothrombosis Am J Cardiol 103 2009 4A 10A
27. S.K. Venugopal, S. Devaraj, I. Yuhanna, P. Shaul, and I. Jialal Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells Circulation 106 2002 1439 1441
28. Y.H. Jeong, U.S. Tantry, J.H. Min, Y. Park, E.P. Navarese, J.S. Koh, J.R. Park, S.J. Hwang, E.H. Kho, K.P. Bliden, C.H. Kwak, J.Y. Hwang, S. Kim, and P.A. Gurbel Influence of platelet reactivity and inflammation on peri-procedural myonecrosis in East Asian patients undergoing elective percutaneous coronary intervention Int J Cardiol 168 2013 427 435
29. D.W. Park, S.W. Lee, S.C. Yun, H.G. Song, J.M. Ahn, J.Y. Lee, W.J. Kim, S.J. Kang, Y.H. Kim, C.W. Lee, S.W. Park, and S.J. Park A point-of-care platelet function assay and C-reactive protein for prediction of major cardiovascular events after drug-eluting stent implantation J Am Coll Cardiol 58 2011 2630 2639